Advances in Cancer Research Described in 15th Cancer Progress Report
MONDAY, Sept. 22, 2025 -- Progress in cancer research, including approval of 20 new anticancer therapeutics in the past year, is described in the 15th edition of the AACR Cancer Progress Report, published by the American Association for Cancer Research (AACR).
AACR President Lillian L. Siu, M.D., from the University of Toronto, and colleagues presented the latest statistics on cancer incidence and mortality and highlighted recent scientific advances.
The authors noted that from 1991 to 2023, there was a 34 percent reduction in the overall cancer death rate, resulting in more than 4.5 million lives saved. Between July 1, 2024, and June 30, 2025, 20 new anticancer therapeutics, eight previously approved anticancer therapeutics for new cancer treatments, two new devices, two minimally invasive tests for colorectal cancer screening, and several artificial intelligence-based tools for early detection and diagnosis were approved by the U.S. Food and Drug Administration. Advances in immunotherapy include the first T-cell receptor T-cell therapy that is beneficial for patients with synovial sarcoma, a new therapeutic antibody targeting a novel protein on stomach cells, and approval of an immune checkpoint inhibitor for treatment of anal cancer. Advances in precision medicine include a new combination regimen for ovarian cancer, approval of IDH-targeted therapy for brain tumors in young adults, and a new antibody-drug conjugate for breast cancer and lung cancer.
"Technological innovations are fueling rapid advances to detect cancer earlier and develop more precise treatments that have the potential to both extend life and preserve its quality," Siu said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Remote Access to Urinary Incontinence Treatments Aids Women Veterans
MONDAY, Sept. 22, 2025 -- Receiving remote behavioral urinary incontinence (UI) treatment through either a mobile health app or video visit improves symptoms among women veterans...
Population Aging Contributes to Burden of Musculoskeletal Disorders
MONDAY, Sept. 22, 2025 -- Population aging is the largest contributor to the increasing burden of musculoskeletal (MSK) disorders in about one-third of countries, according to a...
Circulating Tumor HPV DNA Can ID HPV+OPSCC Years Before Diagnosis
MONDAY, Sept. 22, 2025 -- Circulating tumor human papillomavirus DNA (ctHPVDNA) can be detected in the blood years prior to HPV-associated oropharyngeal squamous cell carcinoma...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.